Taithera is a revolutionary nanomedicine bone targeted drug delivery and controlled release platform technology for the treatment of musculoskeletal conditions focused initially on fracture healing & bone cancer (osteosarcoma is our first oncology target).
Taithera executive summary elab

No Comments Yet.

Leave a Reply

You must be logged in to post a comment.